Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the panuveitis market?

The market for panuveitis has seen swift expansion in recent years. Its current size of $4.05 billion in 2024 is set to increase to $4.47 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.5%. Numerous factors have contributed to the market’s success in the past, including the increased occurrence of autoimmune and infectious diseases, rising usage of corticosteroids, greater acceptance of biologics, a heightened need for ophthalmic imaging, and increasing research funding directed towards infectious causes.

What will be the panuveitis market size in the future?

Expectations are high for the panuveitis market to experience significant expansion in the coming years, with a projected value of $6.58 billion in 2029, reflecting a compound annual growth rate (CAGR) of 10.2%. The forecasted growth throughout this period is likely to be driven by several factors including the surge in the usage of biologic therapies, the growing need for personalized medical treatment, increased incidences of diseases linked to uveitis, enhancement in ophthalmic research funding, and a general increase in disease awareness. Key trends anticipated during this period involve a rising uptake of biologic therapies, continued progress in sustained-release drug delivery technologies, widened scope for personalized medicine, advancements in AI-powered diagnostic and treatment methods, and an upswing in minimally invasive surgical techniques.

Get your panuveitis market report here!

https://www.thebusinessresearchcompany.com/report/panuveitis-global-market-report

What main drivers are fueling expansion in the panuveitis market?

An increasing incidence of autoimmune conditions is predicted to fuel the future expansion of the panuveitis market. These disorders occur when the immune system erroneously targets and attacks the body’s own healthy cells and tissues. The escalating prevalence of autoimmune diseases can be attested to factors such as genetic susceptibility, environmental elements such as pollution and dietary shifts, and enhanced exposure to certain infections and stressors that might induce immune system disruptions. Autoimmune disorders inspire advancements in panuveitis treatment by prompting research into immune system regulation, given that numerous panuveitis instances are associated with autoimmune action. For instance, it was reported by the University of Oxford, a renowned research university in the UK, that as of May 2023, autoimmune disorders afflicted 10% of the global population, with women and men affected rates being 13% and 7% respectively. Consequently, the burgeoning prevalence of autoimmune conditions is key to the growth of the panuveitis market.

What key areas define the segmentation of the global panuveitis market?

The panuveitis market covered in this report is segmented –

1) By Type: Infectious Panuveitis, Non-Infectious Panuveitis

2) By Treatment: Pharmacological, Surgical, Phototherapy

3) By Route Of Administration: Oral, Intravitreal, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Infectious Panuveitis: Bacterial Panuveitis, Viral Panuveitis, Fungal Panuveitis, Parasitic Panuveitis

2) By Non-Infectious Panuveitis: Autoimmune-Related Panuveitis, Idiopathic Panuveitis, Drug-Induced Panuveitis

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21244&type=smp

Who are the dominant players expanding their reach in the panuveitis market?

Major companies operating in the panuveitis market are Pfizer Inc., AbbVie, Boehringer Ingelheim International GmbH, Amgen, Teva Pharmaceuticals, Sandoz, Organon group of companies, Zydus Lifesciences Ltd., Mallinckrodt plc, Alvotech, EyePoint Pharmaceuticals Inc., Affibody Medical AB, Alumis Inc., Fujifilm Kyowa Kirin Biologics Co. Ltd., Revolo Biotherapeutics Ltd., Tarsier Pharma, Priovant Therapeutics Inc., Mylan N.V., Clearside Biomedical Inc., pSivida Corp.

What emerging trends are influencing the growth of the panuveitis market?

Prominent players in the panuveitis market are prioritizing the advancement of slow-release intravitreal injection formulations to enhance patient adherence and results. This method of drug delivery gradually introduces medication into the vitreous humor of the eye over an extended period, promoting sustained therapeutic benefits while decreasing the necessity for regular dosing. For example, in August 2022, Tarsier Pharma, a company based in Israel that is in the clinical-stage, disclosed the creation of TRS02, a proposed immunomodulator meant for treating retinal diseases. This experimental treatment seeks to tackle several conditions at the back of the eye that are marked by underlying inflammatory pathologies, like posterior uveitis (panuveitis), and diabetic macular edema. TRS02 derives from Tarsier’s exclusive technology platform and is presently moving towards the submission of an investigational new drug (IND) after successful preclinical achievements.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21244

Which regions are emerging as leaders in the panuveitis market?

North America was the largest region in the panuveitis market in 2024. The regions covered in the panuveitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Stem Cell/Cord Blood Banking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Blood Bank Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-bank-global-market-report

Diabetic Kidney Disease Global Market Report 2025

https://thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: